Challenges in Inflammatory Bowel Disease, 2d ed.9781405122344 Challenges in inflammatory bowel disease inflammatory bowel disease n. Abbr. IBD Any of several incurable and debilitating diseases of the gastrointestinal tract characterized by inflammation and obstruction of parts of the intestine. , 2d ed. Ed. by Derek Jewell et al. Blackwell Publishing 2006 400 pages $129.95 Hardcover RC862 In this update of the 2001 edition, the editors (affiliated with the Radcliffe Hospital, UK, Mayo Clinic, and U. of Toronto) introduce the surge in interest in the mechanisms of inflammation, its genetic determinants, and the development of designer drugs designer drugs, n.pl the synthetic organic compounds that are designed as analogs of illicit drugs and have the same narcotic or other dangerous effects. to treat inflammatory bowel disease, the collective term for Crohn's disease Crohn's disease: see colitis. and ulcerative colitis. International gastroenterologists and scientists examine clues to the cause(s) of IBD IBD abbr. inflammatory bowel disease Inflammatory bowel disease (IBD) Disease in which the lining of the intestine becomes inflamed. Mentioned in: Amebiasis IBD 1. , and challenges, controversies, and advances in the diagnosis and management of these serious chronic GI conditions and their complications. They also treat special management concerns including the impact of IBD on pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children. pe·di·at·ric adj. Of or relating to pediatrics. and pregnant patients, and the feasibility of prognostic predictions (including, intriguingly, the possible protective role of appendectomies). ([c]20062005 Book News, Inc., Portland, OR) |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion